Rx-To-OTC “Switchability” Initiation Rights May Require Legislation – Juhl
This article was originally published in The Tan Sheet
Executive Summary
Legislative action may be necessary to clarify who controls the Rx-to-OTC switch potential of a drug, University of Pittsburgh Vice Chancellor for Research Conduct & Compliance Randy Juhl, PhD, asserted